Reshma Kewalramani
Overview
Reshma Kewalramani received an average of $10M in total compensation, including $1M in salary, at Vertex Pharmaceuticals from 2019 to 2021.
Source: SEC filings on April 7, 2022 and April 28, 2020.
Related executives
We found 19 more executives who work or worked at Vertex Pharmaceuticals.
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
Stuart Arbuckle
Vertex Pharmaceuticals
Chief Operating Officer
Nia Tatsis
Vertex Pharmaceuticals
EVP & Chief Regulatory and Quality Officer
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
Paul Silva
Vertex Pharmaceuticals
SVP & Corporate Controller
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
Jeffrey Chodakewitz
Vertex Pharmaceuticals